For partisans
of Death Valley those who are planning to conduct a clinical trial
there is
very useful report. Highly recommended. Just a couple of figures which
explain the trends and illustrate Eroom’s law
Our research has established that Phase III trials are, by far, the biggest
expense, and the biggest risk, of new drug development. In fact, we have found
that Phase III trials are even more expensive than is commonly thought. That
expense distorts the drug-development system so that it does not efficiently and
rationally allocate time and money to find new medications. Regulators block
useful drugs from reaching patients. Researchers are discouraged from attempting
to serve the most numerous populations of patients. And investors face the
prospect of spending vast sums for nothing.
Well, the authirs are probably.... comunists?
Well, the authirs are probably.... comunists?
No comments:
Post a Comment